Hybrid effectiveness-implementation trial of massed ptsd treatment in a community substance use program

Active Project Grant Awarded Last action

Award ID
R01MH132720
Recipient
Awarding agency
Obligated
$2,127,719

Award facts

Assistance listing
93.242 Mental Health Research Grants
Completion date 46% complete
Place of performance
Piscataway, NJ 08854, USA

Award details come from USAspending.gov.

Description

Abstract
Over 20 studies have shown that prolonged exposure (PE) is a highly efficacious and effective treatment for posttraumatic stress disorder (PTSD). While PE has been disseminated across many types of treatment settings, IT is still rarely available to substance using populations. This is unfortunate because CO-occurrence of PTSD and substance use disorder (SUD) is extremely common, research points to the importance of treating both disorders concurrently with effective treatments, and numerous studies have shown PE to be safe and effective for PTSD comorbid with SUD. One reason for poor dissemination may be that when PE is available to SUD patients, treatment dropout is high and effect sizes are smaller for PTSD/SUD studies than for PRIMARY PTSD. Higher PE attendance is associated with greater benefit over other treatment. A possible way to enhance effectiveness is to offer PE in a massed format (M-PE; i.e., multiple sessions per week instead of once weekly). For PTSD, M-PE has been shown to be effective and reduce drop out compared to weekly PE. Although most studies of PTSD/SUD treatment have been in outpatient settings, there is indication that M-PE initiated in intensive outpatient (IOP) SUD treatment can improve attendance and outcomes. Taken together, the research suggests that initiating PE in a massed format in IOP SUD treatment is an extremely promising strategy to improve PTSD/SUD outcomes. A critical next step is a pragmatic hybrid type I randomized clinical trial of M-PE initiated in IOP SUD treatment. We propose to compare M-PE with treatment as usual (TAU) to SUD treatment as usual only (SUD care including a weekly trauma skills group) at the gateway community services, INC., a nationally recognized leader in community SUD treatment. Participants will be 168 male and female GCS patients with PTSD/SUD. Our central hypotheses are that M-PE will result in greater reductions in PTSD symptoms and substance use as compared to TAU. Our PRIMARY aim is to compare the effectiveness of M-PE to TAU in IOP SUD treatment in impacting PTSD symptoms and substance use. We hypothesize that M- PE will show greater improvements in PTSD symptom severity at study treatment completion and 1-, 3-, and 6- months follow-up and less substance use at study treatment completion, 1-, 3-, and 6-months follow-up. We will also explore differences in treatment arms on patient-centered outcomes, including days of (non-PRIMARY) substance use, depressive symptoms, functioning, quality of life, suicidal ideation, and participant satisfaction. We will examine gender as a moderator and changes in trauma related cognitions, cravings, and their temporal association as mediators of change in PTSD and substance use. Finally, we will conduct a mixed-method process evaluation to understand patients', providers' and stakeholders' experiences with M-PE, explore barriers to integrating M-PE into IOP SUD treatment, and identify strategies for widespread implementation.

Transactions

Action Obligated Date
Amendment $664,780
Amendment $708,672
Amendment $0
Original award $754,267

Subawards

Subrecipient Amount Awarded
University Of California, San Diego Hybrid Effectiveness-Implementation Trial of Massed PTSD Treatment in a Community Substance Use Program $124,052
Regents Of The University Of Minnesota $64,068
Gateway Community Services Inc. $159,426
Regents Of The University Of Minnesota $47,685
University Of California, San Diego $121,783
Gateway Community Services Inc. $161,358
Regents Of The University Of Minnesota $47,796
Gateway Community Services Inc. $171,052
University Of California, San Diego $125,789

Quick answers

Who received award R01MH132720?

R01MH132720 was awarded to Rutgers, The State University by National Institute of Mental Health (National Institutes of Health) on September 3, 2024.

How much is award R01MH132720 worth?

$2,127,719 has been obligated on R01MH132720.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award